Home › Markets › Health Care › CRBP

Corbus Pharmaceuticals Holdings Inc. (CRBP)

CRBP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$4.78
-9.30% on the day
Market cap
$92.5M
Micro cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerCRBP on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001595097
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2022-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-08-07
Latest annual report10-K2026-03-09
Latest quarterly / interim10-Q2026-08-06
Latest current report8-K2026-09-14
Latest proxyDEFA14A2026-04-16

Source: SEC EDGAR submissions feed, 804 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ANIXAnixa Biosciences Inc.$2.67-5.99%$92.8M
RTSNRetension Pharmaceuticals Inc.$11.63+2.74%$91.7M
BMEABiomea Fusion Inc.$1.26-7.35%$91.3M
IMUXImmunic Inc.$6.89-13.33%$94.0M
OKUROnKure Therapeutics Inc.$2.35-3.10%$95.0M
MISTMilestone Pharmaceuticals Inc. Common Shares$0.7658-4.93%$95.3M
RLYBRallybio Corporation$16.72-0.42%$88.8M
AARDAardvark Therapeutics Inc.$4.04-9.21%$88.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier